Summit Clinical Research, s.r.o

Bratislava 83101

3 studies enrolling now · 8 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Malignant Solid Tumor, Atopic Dermatitis, Chronic Myelomonocytic Leukemia, Dermatitis, Dermatitis, Atopic, Eczema, Genetic Diseases, Inborn, Healthy, Hepatic Impairment, Hypersensitivity, Hypersensitivity, Immediate

Studies at this site

• Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment — Recruiting now
• Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment — Recruiting now
• A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) — Enrolling by invitation
• A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function — Stopped early
• A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906 — Completed
• Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy — Completed
• Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy — Completed
• Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment — Completed